Emoxypine

DB19172InvestigationalSmall molecule

Emoxypine is under investigation in clinical trial NCT06221826 (MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure).

Chemical structure of Emoxypine
Mechanism
Curator reviewed
Formula / weight
C8H11NO · 137.182 g/mol (avg)
Also known as
2-ethyl-3-hydroxy-6-methylpyridine · 2-ethyl-6-methyl-3-hydroxypyridine · 2-ethyl-6-methyl-3-pyridinol · 3-pyridinol, 2-ethyl-6-methyl- · 6-methyl-2-ethyl-3-hydroxypyridine

Resolves to

Compound
UNIIV247P5H4E1CAS2364-75-2ChEMBLCHEMBL3338326
Structure
InChIKeyJPGDYIGSCHWQCC-UHFFFAOYSA-NSMILESCCC1=NC(C)=CC=C1O
Targets
P30536TSPO

What you can answer from here — as of September 20, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Emoxypine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In